Barely Significant
← all excerpts

miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression.

Oncotarget · 2017 · PMC5589646 · PMID 28903407

Europe PMCDOI
1
hedged sentence
0.0011
closest p · 0.0× alpha
0.0011
boldest claim

The sentences

a significant trendp<0.0011actually significant
Log-rank (Mantel-Cox) testing of all survival curves revealed the survival of AKi-II, miR-331-3p and combination treated mice was significantly different to miR-NC treated mice (p<0.0005), with a Logrank test for trend revealing a significant trend (p<0.0011).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.